ALLMedicine™ Esophageal Motility Disorders Center
Research & Reviews 226 results
https://clinicaltrials.gov/ct2/show/NCT05695456
Jan 25th, 2023 - Eosinophilic esophagitis is an antigen driven esophagitis, that is characterized by symptoms of dysphagia often leading to food impaction, and that leads to strictures and esophageal motility disorders, with a significant impact on quality of life...
https://doi.org/10.1007/s00464-023-09872-4
Surgical Endoscopy; Rasmussen M, Ward MA et. al.
Jan 20th, 2023 - Two common surgical procedures used to treat esophageal motility disorders are laparoscopic Heller myotomy (LHM) with partial fundoplication and per-oral endoscopic myotomy (POEM). The difference in frequency of follow-up interventions following t...
https://doi.org/10.1111/nmo.14519
Neurogastroenterology and Motility : the Official Journal... Patel D, Khodadadi A et. al.
Dec 30th, 2022 - Opioid-induced esophageal dysmotility (OIED) includes spastic esophageal motility disorders, increasingly recognized in the contemporary opioid epidemic. We assessed functional lumen imaging probe (FLIP) findings in diagnosing OIED. Symptomatic pa...
https://clinicaltrials.gov/ct2/show/NCT05629325
Nov 29th, 2022 - Esophageal motility disorders can be characterized by poor esophageal motility with impaired clearance of the esophagus. Examples are Ineffective Esophageal Motility (IEM, >70% of the swallows are ineffective or ≥50% are failed) and Absent Contrac...
https://doi.org/10.1016/j.amjsurg.2022.10.036
American Journal of Surgery; Caudell CW, Covil EP et. al.
Nov 14th, 2022 - The purpose of our study was to evaluate the use of minimally invasive Marshmallow Swallow Study (MSS) as a preoperative screening technique for patients and correlate marshmallow results with High Resolution Manometry (HRM) results and post-opera...
Guidelines 1 results
https://doi.org/10.1111/nmo.14182
Neurogastroenterology and Motility : the Official Journal... Khan A, Yadlapati R et. al.
Jul 1st, 2021 - The recommended diagnostic criteria for achalasia have been recently updated by Chicago Classification version 4.0 (CCv4.0), the widely accepted classification scheme for esophageal motility disorders using metrics from high-resolution manometry (...
Clinicaltrials.gov 23 results
https://clinicaltrials.gov/ct2/show/NCT05695456
Jan 25th, 2023 - Eosinophilic esophagitis is an antigen driven esophagitis, that is characterized by symptoms of dysphagia often leading to food impaction, and that leads to strictures and esophageal motility disorders, with a significant impact on quality of life...
https://clinicaltrials.gov/ct2/show/NCT05629325
Nov 29th, 2022 - Esophageal motility disorders can be characterized by poor esophageal motility with impaired clearance of the esophagus. Examples are Ineffective Esophageal Motility (IEM, >70% of the swallows are ineffective or ≥50% are failed) and Absent Contrac...
https://clinicaltrials.gov/ct2/show/NCT05500196
Aug 15th, 2022 - • The primary outcome of the study is the incidence of significant reflux esophagitis (≥grade B) in cases with standard and extended gastric myotomies at 6 months after POEM Secondary outcomes: Significant esophageal acid exposure (>6%) as defined...
https://clinicaltrials.gov/ct2/show/NCT04074356
Aug 5th, 2022 - Dysphagia, or difficulty with swallowing, is a common symptom affecting nearly 9.4 million individuals or 4% of the US population. High resolution esophageal manometry is currently considered the gold standard test for evaluation and diagnosis of ...
https://clinicaltrials.gov/ct2/show/NCT05432843
Jul 6th, 2022 - Globus, defined as a feeling of a lump in the throat, unexplained by structural lesions, GERD, or histopathology-based esophageal motility disorders, is a frequently occurring symptom of unknown etiology. Today there is no appropriate treatment fo...
News 17 results
https://www.mdedge.com/gihepnews/article/255934/upper-gi-tract/then-and-now-lifetime-advancement-upper-gi
David A. Katzka, MD, MDedge News
Jul 1st, 2022 - Fifteen years is a lifetime for the advancement of medical research. This seems particularly true for upper GI tract disorders.
https://www.mdedge.com/gihepnews/article/255934/upper-gi-tract/then-and-now-lifetime-advancement-upper-gi-tract
David A. Katzka, MD
Jul 1st, 2022 - Fifteen years is a lifetime for the advancement of medical research. This seems particularly true for upper GI tract disorders.
https://www.onclive.com/view/tidutamab-shows-early-tolerability-active-immune-profile-in-advanced-neuroendocrine-tumors
Nov 15th, 2021 - Tidutamab (previously XmAb18087) was found to be well tolerated with a best overall response of stable disease in patients with advanced, well-differentiated neuroendocrine tumors (NETs) of pancreatic, gastrointestinal (GI), lung and undetermined ...
https://www.medscape.com/viewarticle/949136
Apr 13th, 2021 - The field of esophagology was transformed by the pioneering work of the late Dr Ray Clouse, who developed color topographic plots to more accurately assess esophageal motility. Clouse's spirit of innovation in this area has since been taken up by ...
https://www.mdedge.com/internalmedicine/article/234665/gastroenterology/normal-flip-findings-usually-ruled-out-esophageal
Amy Karon
Jan 15th, 2021 - Most patients with normal findings on functional luminal imaging probe (FLIP) showed no clinical evidence of a major esophageal motor disorder, even when their high-resolution manometry (HRM) test results were abnormal, according to the results of.